ArticlePediatric rheumatology online journal2026
Association of persistent oxidative stress markers with coronary artery abnormalities in Kawasaki disease patients on follow-up.
Article in Pediatric rheumatology online journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKawasaki disease (KD) is associated with long-term vascular sequelae, including persistent endothelial abnormalities. Data on laboratory-based markers of oxidative stress during long-term follow-up of KD patients from developing countries are limited. This study aimed to evaluate extracellular nitric oxide metabolites and neutrophil-derived reactive oxygen species (ROS) in patients with KD during follow-up and to explore their associations with coronary artery abnormalities (CAAs).
methodsIn this prospective, single-centre study, 62 children with KD and 20 age- and gender-matched healthy controls (HC) were enrolled. KD patients were stratified into three groups based on time since diagnosis and further categorised by the presence or absence of CAAs. Serum nitrite and nitrate levels were measured as indicators of extracellular nitric oxide metabolism. Neutrophil ROS production was assessed using a dihydrorhodamine-123 flow cytometric assay.
resultsSerum nitrite levels were comparable across the 3 groups (Group 1: 3.46 ± 1.64; Group 2: 5.04 ± 2.55; Group 3: 5.22 ± 3.00) and HC (3.33 ± 1.98) (p = 0.06). The serum nitrate levels in KD patients across all three groups (Group 1: 63.07 ± 41.32; Group 2: 58.63 ± 27.12; Group 3: 64.57 ± 26.36) were also comparable to HC (57.49 ± 8.68) (p = 0.43). In subgroup analysis, serum nitrate levels and serum nitrite levels in KD patients with CAAs and without CAAs were comparable (Group 1: p = 0.60; Group 2: p > 0.99; Group 3: p = 0.10) and (Group 1: p > 0.99; Group 2: p > 0.99; Group 3: p = 0.90), respectively. Neutrophil ROS production (ΔMFI) was increased in KD patients, with a significant rise observed in the intermediate follow-up group 2 (> 1.5-3 years) compared with healthy controls (p = 0.03). No significant correlations were found between oxidative stress markers and systemic inflammatory parameters.
conclusionChildren with KD exhibit persistent oxidative stress during follow-up, as evidenced by increased neutrophil ROS production, indicating ongoing cellular oxidative activity. Elevated ROS may serve as an accessible biomarker for CAAs and long-term cardiovascular risk in KD patients on follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.